Glycogen Synthase Kinase-3 in Neurological Diseases View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2012-05-02

AUTHORS

Oksana Kaidanovich-Beilin , James Robert Woodgett

ABSTRACT

Glycogen synthase kinase-3 (GSK-3) occupies an unusual niche in cellular regulation via its negative regulation of a series of important cellular target proteins coupled with its own sensitivity to several major signaling pathways including the Wnt, Notch, Hedgehog, and insulin systems. This protein kinase thus has multiple physiological functions depending on the cell or tissue type. Mouse genetic models in which the two mammalian isoforms (known as GSK-3a and GSK-3b) have been globally or tissue-specifically inactivated or activated have revealed roles in behavior, neurodegenerative diseases, and cognition. The activity of the protein kinase is also influenced directly or indirectly by a series of neuroactive drugs including lithium and psychotropic agents. In this review, we describe the modes of regulation, the molecular targets lying downstream and the association of dysfunction of GSK-3 in various neurological disorders including bipolar disorder, schizophrenia, and neurodegeneration as well as discuss possible strategies that may target GSK-3 for therapeutic benefit. More... »

PAGES

153-188

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-61779-824-5_9

DOI

http://dx.doi.org/10.1007/978-1-61779-824-5_9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032646419


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Genetics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.250674.2", 
          "name": [
            "Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaidanovich-Beilin", 
        "givenName": "Oksana", 
        "id": "sg:person.0575661026.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575661026.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada", 
          "id": "http://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada", 
            "Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woodgett", 
        "givenName": "James Robert", 
        "id": "sg:person.0731233037.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731233037.88"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2012-05-02", 
    "datePublishedReg": "2012-05-02", 
    "description": "Glycogen synthase kinase-3 (GSK-3) occupies an unusual niche in cellular regulation via its negative regulation of a series of important cellular target proteins coupled with its own sensitivity to several major signaling pathways including the Wnt, Notch, Hedgehog, and insulin systems. This protein kinase thus has multiple physiological functions depending on the cell or tissue type. Mouse genetic models in which the two mammalian isoforms (known as GSK-3a and GSK-3b) have been globally or tissue-specifically inactivated or activated have revealed roles in behavior, neurodegenerative diseases, and cognition. The activity of the protein kinase is also influenced directly or indirectly by a series of neuroactive drugs including lithium and psychotropic agents. In this review, we describe the modes of regulation, the molecular targets lying downstream and the association of dysfunction of GSK-3 in various neurological disorders including bipolar disorder, schizophrenia, and neurodegeneration as well as discuss possible strategies that may target GSK-3 for therapeutic benefit.", 
    "editor": [
      {
        "familyName": "Mukai", 
        "givenName": "Hideyuki", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-61779-824-5_9", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-61779-823-8", 
        "978-1-61779-824-5"
      ], 
      "name": "Protein Kinase Technologies", 
      "type": "Book"
    }, 
    "keywords": [
      "glycogen synthase kinase-3", 
      "synthase kinase-3", 
      "protein kinase", 
      "kinase 3", 
      "cellular target proteins", 
      "major signaling pathways", 
      "mode of regulation", 
      "mouse genetic models", 
      "multiple physiological functions", 
      "cellular regulation", 
      "mammalian isoforms", 
      "negative regulation", 
      "unusual niche", 
      "target proteins", 
      "signaling pathways", 
      "physiological functions", 
      "tissue types", 
      "molecular targets", 
      "genetic models", 
      "kinase", 
      "neurodegenerative diseases", 
      "regulation", 
      "neuroactive drugs", 
      "Wnt", 
      "insulin system", 
      "niche", 
      "hedgehog", 
      "protein", 
      "isoforms", 
      "neurological diseases", 
      "pathway", 
      "neurological disorders", 
      "neurodegeneration", 
      "cells", 
      "Notch", 
      "target", 
      "possible strategies", 
      "tissue", 
      "therapeutic benefit", 
      "role", 
      "activity", 
      "disease", 
      "function", 
      "bipolar disorder", 
      "disorders", 
      "association", 
      "types", 
      "agents", 
      "review", 
      "strategies", 
      "dysfunction", 
      "sensitivity", 
      "drugs", 
      "own sensitivity", 
      "series", 
      "system", 
      "mode", 
      "model", 
      "schizophrenia", 
      "behavior", 
      "benefits", 
      "cognition", 
      "lithium", 
      "psychotropic agents"
    ], 
    "name": "Glycogen Synthase Kinase-3 in Neurological Diseases", 
    "pagination": "153-188", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032646419"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-61779-824-5_9"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-61779-824-5_9", 
      "https://app.dimensions.ai/details/publication/pub.1032646419"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_40.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-61779-824-5_9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-61779-824-5_9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-61779-824-5_9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-61779-824-5_9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-61779-824-5_9'


 

This table displays all metadata directly associated to this object as RDF triples.

138 TRIPLES      22 PREDICATES      89 URIs      81 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-61779-824-5_9 schema:about anzsrc-for:06
2 anzsrc-for:0601
3 anzsrc-for:0604
4 schema:author N83ce6bf97a724c439101a3e6b4b7aed7
5 schema:datePublished 2012-05-02
6 schema:datePublishedReg 2012-05-02
7 schema:description Glycogen synthase kinase-3 (GSK-3) occupies an unusual niche in cellular regulation via its negative regulation of a series of important cellular target proteins coupled with its own sensitivity to several major signaling pathways including the Wnt, Notch, Hedgehog, and insulin systems. This protein kinase thus has multiple physiological functions depending on the cell or tissue type. Mouse genetic models in which the two mammalian isoforms (known as GSK-3a and GSK-3b) have been globally or tissue-specifically inactivated or activated have revealed roles in behavior, neurodegenerative diseases, and cognition. The activity of the protein kinase is also influenced directly or indirectly by a series of neuroactive drugs including lithium and psychotropic agents. In this review, we describe the modes of regulation, the molecular targets lying downstream and the association of dysfunction of GSK-3 in various neurological disorders including bipolar disorder, schizophrenia, and neurodegeneration as well as discuss possible strategies that may target GSK-3 for therapeutic benefit.
8 schema:editor N8fb7f14d142f40429acb35c01bf62b37
9 schema:genre chapter
10 schema:isAccessibleForFree false
11 schema:isPartOf Na3749e72ac2e48d19bb2d8f1482c359a
12 schema:keywords Notch
13 Wnt
14 activity
15 agents
16 association
17 behavior
18 benefits
19 bipolar disorder
20 cells
21 cellular regulation
22 cellular target proteins
23 cognition
24 disease
25 disorders
26 drugs
27 dysfunction
28 function
29 genetic models
30 glycogen synthase kinase-3
31 hedgehog
32 insulin system
33 isoforms
34 kinase
35 kinase 3
36 lithium
37 major signaling pathways
38 mammalian isoforms
39 mode
40 mode of regulation
41 model
42 molecular targets
43 mouse genetic models
44 multiple physiological functions
45 negative regulation
46 neuroactive drugs
47 neurodegeneration
48 neurodegenerative diseases
49 neurological diseases
50 neurological disorders
51 niche
52 own sensitivity
53 pathway
54 physiological functions
55 possible strategies
56 protein
57 protein kinase
58 psychotropic agents
59 regulation
60 review
61 role
62 schizophrenia
63 sensitivity
64 series
65 signaling pathways
66 strategies
67 synthase kinase-3
68 system
69 target
70 target proteins
71 therapeutic benefit
72 tissue
73 tissue types
74 types
75 unusual niche
76 schema:name Glycogen Synthase Kinase-3 in Neurological Diseases
77 schema:pagination 153-188
78 schema:productId N045c2c1cf2774b468fa0aee875980cdb
79 N2ada6ac828984fbbb77eb40dc2b95c6c
80 schema:publisher N256b56df5c564aaf88c9105635bc7476
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032646419
82 https://doi.org/10.1007/978-1-61779-824-5_9
83 schema:sdDatePublished 2022-09-02T16:15
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N368c92cc701e4713bf2c3a7a585c09ca
86 schema:url https://doi.org/10.1007/978-1-61779-824-5_9
87 sgo:license sg:explorer/license/
88 sgo:sdDataset chapters
89 rdf:type schema:Chapter
90 N0042d01dead14870bc6fdbab1b4ca323 rdf:first sg:person.0731233037.88
91 rdf:rest rdf:nil
92 N045c2c1cf2774b468fa0aee875980cdb schema:name dimensions_id
93 schema:value pub.1032646419
94 rdf:type schema:PropertyValue
95 N256b56df5c564aaf88c9105635bc7476 schema:name Springer Nature
96 rdf:type schema:Organisation
97 N2ada6ac828984fbbb77eb40dc2b95c6c schema:name doi
98 schema:value 10.1007/978-1-61779-824-5_9
99 rdf:type schema:PropertyValue
100 N368c92cc701e4713bf2c3a7a585c09ca schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 N83ce6bf97a724c439101a3e6b4b7aed7 rdf:first sg:person.0575661026.37
103 rdf:rest N0042d01dead14870bc6fdbab1b4ca323
104 N8fb7f14d142f40429acb35c01bf62b37 rdf:first Nfa48304950d6420494156f48b989351c
105 rdf:rest rdf:nil
106 Na3749e72ac2e48d19bb2d8f1482c359a schema:isbn 978-1-61779-823-8
107 978-1-61779-824-5
108 schema:name Protein Kinase Technologies
109 rdf:type schema:Book
110 Nfa48304950d6420494156f48b989351c schema:familyName Mukai
111 schema:givenName Hideyuki
112 rdf:type schema:Person
113 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
114 schema:name Biological Sciences
115 rdf:type schema:DefinedTerm
116 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
117 schema:name Biochemistry and Cell Biology
118 rdf:type schema:DefinedTerm
119 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
120 schema:name Genetics
121 rdf:type schema:DefinedTerm
122 sg:person.0575661026.37 schema:affiliation grid-institutes:grid.250674.2
123 schema:familyName Kaidanovich-Beilin
124 schema:givenName Oksana
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575661026.37
126 rdf:type schema:Person
127 sg:person.0731233037.88 schema:affiliation grid-institutes:grid.17063.33
128 schema:familyName Woodgett
129 schema:givenName James Robert
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731233037.88
131 rdf:type schema:Person
132 grid-institutes:grid.17063.33 schema:alternateName Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
133 schema:name Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
134 Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
135 rdf:type schema:Organization
136 grid-institutes:grid.250674.2 schema:alternateName Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
137 schema:name Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
138 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...